(SLAB) Silicon Laboratories - Ratings and Ratios
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US8269191024
Microcontrollers, Sensors, IoT, Wireless, Mixed-Signal
EPS (Earnings per Share)
Revenue
Dividends
Currently no dividends paid| Risk via 5d forecast | |
|---|---|
| Volatility | 45.7% |
| Value at Risk 5%th | 69.4% |
| Relative Tail Risk | -7.78% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.32 |
| Alpha | -15.91 |
| CAGR/Max DD | -0.04 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.447 |
| Beta | 1.831 |
| Beta Downside | 1.948 |
| Drawdowns 3y | |
|---|---|
| Max DD | 55.35% |
| Mean DD | 32.13% |
| Median DD | 32.22% |
Description: SLAB Silicon Laboratories January 09, 2026
Silicon Laboratories (NASDAQ: SLAB) is a fabless semiconductor firm that designs analog-intensive mixed-signal solutions, notably wireless microcontrollers and sensor products, for a broad spectrum of industrial and commercial IoT applications-from smart-home cameras and HVAC controls to electric-vehicle charging stations and medical wearables.
In its most recent fiscal year (2023) the company reported revenue of roughly $1.0 billion, a year-over-year increase of about 10 % driven by strong demand for low-power connectivity chips in the industrial IoT segment; gross margins stayed near 55 % while operating cash flow exceeded $300 million, reflecting disciplined cost management. Key macro drivers include the U.S. CHIPS Act-funded expansion of domestic semiconductor capacity and the accelerating adoption of 5G-enabled edge devices, both of which underpin the long-term growth outlook for mixed-signal components.
If you’re looking to deepen your quantitative analysis, a quick look at ValueRay’s detailed valuation models for SLAB could surface additional upside scenarios worth exploring.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income (-86.0m TTM) > 0 and > 6% of Revenue (6% = 44.6m TTM) |
| FCFTA 0.06 (>2.0%) and ΔFCFTA 7.24pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 68.29% (prev 98.19%; Δ -29.90pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.08 (>3.0%) and CFO 97.5m > Net Income -86.0m (YES >=105%, WARN >=100%) |
| NO Net Debt/EBITDA fails (EBITDA <= 0) |
| Current Ratio 4.49 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (32.8m) change vs 12m ago 1.63% (target <= -2.0% for YES) |
| Gross Margin 55.89% (prev 53.88%; Δ 2.00pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 59.37% (prev 40.42%; Δ 18.95pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -80.80 (EBITDA TTM -41.0m / Interest Expense TTM 1.02m) >= 6 (WARN >= 3) |
Altman Z'' 10.07
| (A) 0.40 = (Total Current Assets 652.6m - Total Current Liabilities 145.3m) / Total Assets 1.25b |
| (B) 0.75 = Retained Earnings (Balance) 939.5m / Total Assets 1.25b |
| (C) -0.07 = EBIT TTM -82.5m / Avg Total Assets 1.25b |
| (D) 5.15 = Book Value of Equity 939.7m / Total Liabilities 182.4m |
| Total Rating: 10.07 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 32.71
| 1. Piotroski 4.50pt |
| 2. FCF Yield 1.64% |
| 3. FCF Margin 9.91% |
| 4. Debt/Equity 0.01 |
| 5. Debt/Ebitda 8.33 |
| 6. ROIC - WACC (= -18.71)% |
| 7. RoE -8.04% |
| 8. Rev. Trend -42.18% |
| 9. EPS Trend -61.57% |
What is the price of SLAB shares?
As of January 22, 2026, the stock is trading at USD 145.41 with a total of 419,354 shares traded.
Over the past week, the price has changed by -0.71%, over one month by +7.05%, over three months by +5.77% and over the past year by +6.73%.
Over the past week, the price has changed by -0.71%, over one month by +7.05%, over three months by +5.77% and over the past year by +6.73%.
Is SLAB a buy, sell or hold?
Silicon Laboratories has received a consensus analysts rating of 3.73.
Therefor, it is recommend to hold SLAB.
- Strong Buy: 3
- Buy: 2
- Hold: 6
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the SLAB price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 151.3 | 4.1% |
| Analysts Target Price | 151.3 | 4.1% |
| ValueRay Target Price | 151.6 | 4.3% |
SLAB Fundamental Data Overview January 15, 2026
P/E Forward = 53.7634
P/S = 6.4772
P/B = 4.4528
P/EG = 3.0343
Revenue TTM = 742.8m USD
EBIT TTM = -82.5m USD
EBITDA TTM = -41.0m USD
Long Term Debt = 15.5m USD (from capitalLeaseObligations, last fiscal year)
Short Term Debt = unknown (none)
Debt = 15.5m USD (from shortLongTermDebtTotal, last fiscal year)
Net Debt = -341.4m USD (from netDebt column, last quarter)
Enterprise Value = 4.49b USD (4.81b + Debt 15.5m - CCE 341.4m)
Interest Coverage Ratio = -80.80 (Ebit TTM -82.5m / Interest Expense TTM 1.02m)
EV/FCF = 60.96x (Enterprise Value 4.49b / FCF TTM 73.6m)
FCF Yield = 1.64% (FCF TTM 73.6m / Enterprise Value 4.49b)
FCF Margin = 9.91% (FCF TTM 73.6m / Revenue TTM 742.8m)
Net Margin = -11.58% (Net Income TTM -86.0m / Revenue TTM 742.8m)
Gross Margin = 55.89% ((Revenue TTM 742.8m - Cost of Revenue TTM 327.7m) / Revenue TTM)
Gross Margin QoQ = 57.78% (prev 56.06%)
Tobins Q-Ratio = 3.58 (Enterprise Value 4.49b / Total Assets 1.25b)
Interest Expense / Debt = 1.45% (Interest Expense 226.0k / Debt 15.5m)
Taxrate = 21.0% (US default 21%)
NOPAT = -65.2m (EBIT -82.5m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 4.49 (Total Current Assets 652.6m / Total Current Liabilities 145.3m)
Debt / Equity = 0.01 (Debt 15.5m / totalStockholderEquity, last quarter 1.07b)
Debt / EBITDA = 8.33 (negative EBITDA) (Net Debt -341.4m / EBITDA -41.0m)
Debt / FCF = -4.64 (Net Debt -341.4m / FCF TTM 73.6m)
Total Stockholder Equity = 1.07b (last 4 quarters mean from totalStockholderEquity)
RoA = -6.88% (Net Income -86.0m / Total Assets 1.25b)
RoE = -8.04% (Net Income TTM -86.0m / Total Stockholder Equity 1.07b)
RoCE = -7.60% (EBIT -82.5m / Capital Employed (Equity 1.07b + L.T.Debt 15.5m))
RoIC = -6.09% (negative operating profit) (NOPAT -65.2m / Invested Capital 1.07b)
WACC = 12.62% (E(4.81b)/V(4.83b) * Re(12.66%) + D(15.5m)/V(4.83b) * Rd(1.45%) * (1-Tc(0.21)))
Discount Rate = 12.66% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 1.54%
[DCF Debug] Terminal Value 52.59% ; FCFF base≈73.6m ; Y1≈48.3m ; Y5≈22.0m
Fair Price DCF = 17.84 (EV 244.8m - Net Debt -341.4m = Equity 586.2m / Shares 32.9m; r=12.62% [WACC]; 5y FCF grow -40.0% → 2.90% )
[DCF Warning] FCF declining rapidly (-40.0%), DCF may be unreliable
EPS Correlation: -61.57 | EPS CAGR: -20.88% | SUE: 0.13 | # QB: 0
Revenue Correlation: -42.18 | Revenue CAGR: -0.34% | SUE: 0.39 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.50 | Chg30d=+0.113 | Revisions Net=+4 | Analysts=9
EPS next Year (2026-12-31): EPS=2.69 | Chg30d=+0.203 | Revisions Net=+5 | Growth EPS=+197.1% | Growth Revenue=+17.8%
P/S = 6.4772
P/B = 4.4528
P/EG = 3.0343
Revenue TTM = 742.8m USD
EBIT TTM = -82.5m USD
EBITDA TTM = -41.0m USD
Long Term Debt = 15.5m USD (from capitalLeaseObligations, last fiscal year)
Short Term Debt = unknown (none)
Debt = 15.5m USD (from shortLongTermDebtTotal, last fiscal year)
Net Debt = -341.4m USD (from netDebt column, last quarter)
Enterprise Value = 4.49b USD (4.81b + Debt 15.5m - CCE 341.4m)
Interest Coverage Ratio = -80.80 (Ebit TTM -82.5m / Interest Expense TTM 1.02m)
EV/FCF = 60.96x (Enterprise Value 4.49b / FCF TTM 73.6m)
FCF Yield = 1.64% (FCF TTM 73.6m / Enterprise Value 4.49b)
FCF Margin = 9.91% (FCF TTM 73.6m / Revenue TTM 742.8m)
Net Margin = -11.58% (Net Income TTM -86.0m / Revenue TTM 742.8m)
Gross Margin = 55.89% ((Revenue TTM 742.8m - Cost of Revenue TTM 327.7m) / Revenue TTM)
Gross Margin QoQ = 57.78% (prev 56.06%)
Tobins Q-Ratio = 3.58 (Enterprise Value 4.49b / Total Assets 1.25b)
Interest Expense / Debt = 1.45% (Interest Expense 226.0k / Debt 15.5m)
Taxrate = 21.0% (US default 21%)
NOPAT = -65.2m (EBIT -82.5m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 4.49 (Total Current Assets 652.6m / Total Current Liabilities 145.3m)
Debt / Equity = 0.01 (Debt 15.5m / totalStockholderEquity, last quarter 1.07b)
Debt / EBITDA = 8.33 (negative EBITDA) (Net Debt -341.4m / EBITDA -41.0m)
Debt / FCF = -4.64 (Net Debt -341.4m / FCF TTM 73.6m)
Total Stockholder Equity = 1.07b (last 4 quarters mean from totalStockholderEquity)
RoA = -6.88% (Net Income -86.0m / Total Assets 1.25b)
RoE = -8.04% (Net Income TTM -86.0m / Total Stockholder Equity 1.07b)
RoCE = -7.60% (EBIT -82.5m / Capital Employed (Equity 1.07b + L.T.Debt 15.5m))
RoIC = -6.09% (negative operating profit) (NOPAT -65.2m / Invested Capital 1.07b)
WACC = 12.62% (E(4.81b)/V(4.83b) * Re(12.66%) + D(15.5m)/V(4.83b) * Rd(1.45%) * (1-Tc(0.21)))
Discount Rate = 12.66% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 1.54%
[DCF Debug] Terminal Value 52.59% ; FCFF base≈73.6m ; Y1≈48.3m ; Y5≈22.0m
Fair Price DCF = 17.84 (EV 244.8m - Net Debt -341.4m = Equity 586.2m / Shares 32.9m; r=12.62% [WACC]; 5y FCF grow -40.0% → 2.90% )
[DCF Warning] FCF declining rapidly (-40.0%), DCF may be unreliable
EPS Correlation: -61.57 | EPS CAGR: -20.88% | SUE: 0.13 | # QB: 0
Revenue Correlation: -42.18 | Revenue CAGR: -0.34% | SUE: 0.39 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.50 | Chg30d=+0.113 | Revisions Net=+4 | Analysts=9
EPS next Year (2026-12-31): EPS=2.69 | Chg30d=+0.203 | Revisions Net=+5 | Growth EPS=+197.1% | Growth Revenue=+17.8%
Additional Sources for SLAB Stock
News:
Wall Street Journal |
Benzinga |
Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle